Desai Akshay Nilesh, Kurian Christine Jane, Rafferty William, Behrens Danielle Lajoie, Khrizman Polina
Department of Internal Medicine at Cooper University Healthcare, Camden, NJ, United States.
Department of Medical Oncology and Hematology at MD Anderson Cancer Center at Cooper University Healthcare, Camden, NJ, United States.
Front Oncol. 2024 Feb 19;14:1260474. doi: 10.3389/fonc.2024.1260474. eCollection 2024.
Intra-abdominal desmoplastic small round cell tumor (IDSRCT) is a rare entity (0.2-0.74 cases per million people per year), which predominantly occurs in young men. It may present as an abdominal mass with pain, distention, and constipation. IDSRCT has a very poor prognosis, with 5-year overall survival estimated at 15%-30%. Diagnosis is made with tissue biopsy.
We present a case of a 28-year-old man with a history of schizophrenia and depression who presented to an emergency room (ER) in November 2022 with constipation and pelvic pain. The patient was sent home with a bowel regimen after radiography showed no obstruction. He re-presented for evaluation due to persistent pain. A computerized tomography scan of the abdomen and pelvis (CT A/P) revealed numerous pelvic masses with severe colitis, bilateral moderate hydronephrosis, and metastatic disease in the liver. A colonoscopy showed a mass extending 3 cm from the anus to 10 cm causing a partial obstruction. Biopsy was read as squamous cell carcinoma (SCC). The patient was subsequently admitted to our institution with pelvic pain, nausea, and vomiting. Colorectal surgery performed a colectomy with end-ileostomy due to colonic obstruction. He was evaluated by a medical oncologist, with previous slides requested for review. Initial review was concerning metastatic basaloid SCC with neuroendocrine features and a Ki67 of 70%. Given his recent abdominal surgeries, chemotherapy was delayed until February 2023 when he was started on reduced dose carboplatin and paclitaxel. Tumor specimen was sent for next generation sequencing (NGS) and programmed death-1 ligand 1 (PD-L1) testing. NGS results returned after the first dose of chemotherapy was given and showed a t(11;22) EWSR-WT1 translocation characteristic of desmoplastic small round cell tumor. The patient was supported in the hospital and discharged with oncology follow-up.
As seen in this case, pathology review is essential to ensuring correct diagnosis and appropriate treatment plan. This is especially true when the clinical scenario does not match the listed pathology. Additional diagnostics such as NGS are invaluable in establishing correct diagnosis.
腹腔促结缔组织增生性小圆细胞肿瘤(IDSRCT)是一种罕见疾病(每年每百万人中有0.2 - 0.74例),主要发生于年轻男性。其表现可能为伴有疼痛、腹胀和便秘的腹部肿块。IDSRCT的预后非常差,估计5年总生存率为15% - 30%。通过组织活检进行诊断。
我们报告一例28岁男性患者,有精神分裂症和抑郁症病史,于2022年11月因便秘和盆腔疼痛就诊于急诊室。经X线检查未发现梗阻后,患者接受肠道治疗后回家。因持续疼痛他再次前来评估。腹部和盆腔计算机断层扫描(CT A/P)显示盆腔有多个肿块,伴有严重结肠炎、双侧中度肾积水以及肝脏转移瘤。结肠镜检查显示距肛门3厘米至10厘米处有一肿块,导致部分梗阻。活检结果为鳞状细胞癌(SCC)。随后患者因盆腔疼痛、恶心和呕吐入住我院。由于结肠梗阻,结直肠外科进行了结肠切除术并做了末端回肠造口术。他接受了医学肿瘤学家的评估,并要求复查之前的切片。初步复查结果提示为具有神经内分泌特征的转移性基底样SCC,Ki67为70%。鉴于他近期接受了腹部手术,化疗推迟至2023年2月,当时他开始接受减量的卡铂和紫杉醇治疗。肿瘤标本送去进行二代测序(NGS)和程序性死亡受体1配体1(PD - L1)检测。在给予第一剂化疗后NGS结果返回,显示出促结缔组织增生性小圆细胞肿瘤特征性的t(11;22) EWSR - WT1易位。患者在医院得到支持治疗,出院后接受肿瘤学随访。
如本病例所示,病理复查对于确保正确诊断和制定合适的治疗方案至关重要。当临床情况与所列病理结果不相符时尤其如此。诸如NGS等额外的诊断方法在确立正确诊断方面具有极高价值。